UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF
1934
DATE OF REPORT: August 14, 2002
(DATE OF EARLIEST EVENT REPORTED)
(Exact name of Registrant as specified in its Charter)
| Florida (State or other jurisdiction of incorporation) |
000-20997 (Commission File Number) |
59-3252632 (I. R. S. Employer Identification No.) |
12425 Racetrack Road
Tampa, Florida 33626
(Address of Principal Executive Offices)
(813) 891-9550
(Registrant’s Telephone Number, including area code)
Item 9. Regulation FD Disclosure
On August 14, 2002, SRI/Surgical Express, Inc. submitted to the Securities and Exchange Commission the certification by its chief executive and chief financial officers pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 of the Company’s report on Form 10-Q for the quarter ended June 30, 2002 filed on August 14, 2002.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| SRI/SURGICAL EXPRESS, INC. (Registrant) | |||
| Dated: August 14, 2002 | /s/ James T. Boosales | ||
| James T. Boosales Chief Financial Officer |